Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

Viroclinics-DDL rebrands to Cerba Research

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands) a world leading vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology,

March 18, 2024

More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk

All three higher doses of tirzepatide (Mounjaro) — 10, 12.5, and 15 mg — will be in short supply through early March due to increased

February 7, 2024

Increasing the Dose of Smoking Cessation Treatments Improved Abstinence

Increasing the dosages of varenicline (Chantix) or combined nicotine replacement therapy (CNRT), or switching from CNRT to varenicline, improved abstinence from smoking, a randomized clinical

May 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.